Search

everythinglearnresearchcommunity

for

Search:↓

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Sinsun-yukza-hwan extract promotes hair growth in mice.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Hair loss is significantly linked to symptoms like dry hair, scalp issues, addiction to tobacco or coffee, anxiety, and digestive problems.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

Some alternative treatments for hair loss might work, but more research is needed.

The research found genes that may protect certain scalp cells from hair loss.

Mesenchymal stem cells could potentially help regenerate hair in people with hair loss.

Stem cells can create hair follicles, potentially treating permanent hair loss, and healthy skin and hair depend on mitochondrial function and special fats.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

The document summarized various dermatology studies and case reports.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

PRP therapy is more effective and preferred over minoxidil for hair loss.

Trichodysplasia spinulosa can occur after a heart transplant due to immunosuppressive drugs.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.